In addition, several studies have demonstrated that high expression of MELK was correlated with poorly differentiated phenotypes (malignancy grade) in human astrocytoma and prostate cancers, and is associated with poor prognosis of breast cancer patients [5]. This evidence concerns the gene MELK and breast cancer.